Page last updated: 2024-11-06

farrerol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

farrerol: expectorant principle isolated from leaves of Rhododendron dauricum L; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
RhododendrongenusA plant genus of the family ERICACEAE.[MeSH]EricaceaeThe heath plant family of the order Ericales, subclass Dilleniidae, class Magnoliopsida that are generally shrubs or small trees. Leaves are alternate, simple, and leathery; flowers are symmetrical with a 4- or 5-parted corolla of partly fused petals.[MeSH]
Rhododendron dauricumspecies[no description available]EricaceaeThe heath plant family of the order Ericales, subclass Dilleniidae, class Magnoliopsida that are generally shrubs or small trees. Leaves are alternate, simple, and leathery; flowers are symmetrical with a 4- or 5-parted corolla of partly fused petals.[MeSH]

Cross-References

ID SourceID
PubMed CID442396
CHEMBL ID507611
CHEBI ID67897
MeSH IDM0065494

Synonyms (22)

Synonym
farrerol
C09734
chebi:67897 ,
CHEMBL507611 ,
AC1L9CQK ,
(2s)-5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-dimethyl-2,3-dihydrochromen-4-one
(s)-2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-dimethyl-4-benzopyrone
S9552
AKOS015896732
6,8-dimethyl-4',5,7-trihydroxyflavanone
AC-34143
zinc04098306
(2s)-5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-dimethyl-chroman-4-one
farrerol, >=98% (hplc)
(s)-5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-dimethylchroman-4-one
Q27104948
CS-0008902
HY-N0344
5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-dimethyl-2,3-dihydro-4h-1-benzopyran-4-one
DTXSID40947026
JXY ,
(2~{s})-2-(4-hydroxyphenyl)-6,8-dimethyl-5,7-bis(oxidanyl)-2,3-dihydrochromen-4-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
organic molecular entityAny molecular entity that contains carbon.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (12)

Assay IDTitleYearJournalArticle
AID333836Antifungal activity against azole-sensitive Candida albicans by broth microdilution assay2005Journal of natural products, Dec, Volume: 68, Issue:12
Antifungal flavonoids from Hildegardia barteri.
AID333838Antifungal activity against polyene-resistant Candida glabrata by broth microdilution assay2005Journal of natural products, Dec, Volume: 68, Issue:12
Antifungal flavonoids from Hildegardia barteri.
AID1366141Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by broth microdilution method2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Antibacterial constituents of the plant family Amaryllidaceae.
AID1239713Anti-platelet activity in rat platelet rich plasma assessed as inhibition of ADP and calcium-induced platelet aggregation at 100 uM pre-incubated at 37 degC for 10 mins and measured 30 mins after ADP and calcium addition2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Potential therapeutic agents for circulatory diseases from Bauhinia glauca Benth.subsp. pernervosa. (Da Ye Guan Men).
AID333839Antifungal activity against azole-resistant Candida albicans by broth microdilution assay2005Journal of natural products, Dec, Volume: 68, Issue:12
Antifungal flavonoids from Hildegardia barteri.
AID1773665Inhibition of human recombinant PTP1B (1 to 322 residues) expressed in Escherichia coli at 100 uM using pNPP as substrate preincubated with substrate for 10 mins followed by enzyme addition and measured for 10 mins by absorbance based analysis2021Journal of natural products, 09-24, Volume: 84, Issue:9
Dual High-Resolution α-Glucosidase and PTP1B Inhibition Profiling Combined with HPLC-PDA-HRMS-SPE-NMR Analysis for the Identification of Potentially Antidiabetic Chromene Meroterpenoids from
AID1366140Antibacterial activity against Escherichia coli after 24 hrs by broth microdilution method2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Antibacterial constituents of the plant family Amaryllidaceae.
AID333840Antifungal activity against azole-resistant Candida glabrata by broth microdilution assay2005Journal of natural products, Dec, Volume: 68, Issue:12
Antifungal flavonoids from Hildegardia barteri.
AID1366142Antibacterial activity against Shigella flexneri after 24 hrs by broth microdilution method2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Antibacterial constituents of the plant family Amaryllidaceae.
AID333837Antifungal activity against polyene-resistant Candida albicans by broth microdilution assay2005Journal of natural products, Dec, Volume: 68, Issue:12
Antifungal flavonoids from Hildegardia barteri.
AID1773663Inhibition of Saccharomyces cerevisiae alpha-glucosidase at 100 uM using pNPG as substrate preincubated for 10 mins followed by substrate addition and measured for 35 mins by microplate photometric method2021Journal of natural products, 09-24, Volume: 84, Issue:9
Dual High-Resolution α-Glucosidase and PTP1B Inhibition Profiling Combined with HPLC-PDA-HRMS-SPE-NMR Analysis for the Identification of Potentially Antidiabetic Chromene Meroterpenoids from
AID333841Antifungal activity against azole-resistant Candida krusei by broth microdilution assay2005Journal of natural products, Dec, Volume: 68, Issue:12
Antifungal flavonoids from Hildegardia barteri.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (52)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (5.77)18.7374
1990's0 (0.00)18.2507
2000's2 (3.85)29.6817
2010's32 (61.54)24.3611
2020's15 (28.85)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (3.85%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other50 (96.15%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]